Invesco Ltd. 13D and 13G filings for Phathom Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-09 11:45 am Purchase | 2024-02-07 | 13G | PHATHOM PHARMACEUTICALS INC CO PHAT | Invesco Ltd. IVZ | 3,167,653 5.500% | 960,004 (+43.49%) | Filing |
| 2023-02-02 3:08 pm Purchase | 2023-02-02 | 13G | PHATHOM PHARMACEUTICALS INC CO PHAT | Invesco Ltd. IVZ | 2,207,649 5.300% | 140,293 (+6.79%) | Filing |
| 2022-02-10 11:32 am Purchase | 2022-02-09 | 13G | PHATHOM PHARMACEUTICALS INC CO PHAT | Invesco Ltd. IVZ | 2,067,356 6.600% | 12,918 (+0.63%) | Filing |